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Abstract
One of the 172 UK cases of equine atypical myopathy (EAM) reported to the Atypical Myopathy Alert 
Group (AMAG) in 2014 was that of a five-month old male Przewalski horse (Equus ferus przewalskii), 
resident at ZSL Whipsnade Zoo, UK. The foal presented initially with sudden-onset and repeated 
stretching of the neck as if dysphagic, with progressive weakness (including lying down), sweating 
and an unresponsive demeanour. General anaesthesia, induced with a combination of etorphine, 
midazolam and hyaluronidase, was required for each examination and subsequent treatment of the 
foal.  Initial biochemical analysis showed a markedly increased plasma creatine kinase (CK) activity of 
105,001 U/L, an increased aspartate amino transferase (AST) activity of 4194 U/L and a mildly increased 
inorganic phosphorus concentration of 2.35 mmol/L.  The foal was unresponsive to treatment and had 
to be euthanased. Skeletal musculature and the myocardium showed the most significant pathological 
changes, with histological evidence of rhabdomyolysis, whilst urine organic acid analysis and an 
abnormal organic acid serum profile were supportive of multiple acyl Co-A dehydrogenase deficiency 
typical of EAM. This is the first description of EAM in a non-domestic equid.
Background
In 2014, 172 UK cases of equine atypical myopathy (EAM), 
thought to be associated with ingestion of hypoglycin A as 
found in the seeds of sycamore trees (Acer sp.) (Unger et 
al. 2014; Votion et al. 2014), were reported to the Atypical 
Myopathy Alert Group (AMAG) at the University of Liege, 
Belgium (Dominique Votion, pers. comm.).  One of these cases 
concerned EAM in an exotic equid: a five-month old male 
Przewalski horse (Equus ferus przewalskii), resident at ZSL 
Whipsnade Zoo, Bedfordshire, in late October 2014. 
The foal presented with sudden-onset and repeated stretching 
of the neck as if dysphagic and progressive weakness, including 
lying down, profuse sweating and an unresponsive demeanour 
(Figure 1). Oesophageal obstruction was suspected, although 
other differentials such as ingestion of poisonous plants and 
colic were also considered. 
Procedures and results
Anaesthesia was induced with 1.6 mg etorphine (M99®, 
Vetapharm, UK), 12 mg midazolam (Hypnovel®, Roche, UK) and 
150 IU hyaluronidase (Hyalase®, Wockhardt, UK) administered 
intramuscularly by dart, intubated and maintained with 
2% isoflurane in medical oxygen. The heart rate was steady 
and between 80 and 92 bpm throughout, with a respiratory 
rate of 4–12/min, depending on anaesthetic depth. Rectal 
temperature was 38.7°C throughout. A medium (19 gauge) 
stomach tube was inserted through the nasal passages. Under 
endoscopic direction, numerous attempts had to be made 
before successful passage through the oesophagus into the 
stomach, alleviating a large amount of sweet smelling gas. No 
oesophageal obstruction was evident. Subsequently, 300 ml 
of liquid paraffin was given before removal of the nasogastric 
tube. Further clinical examination was unremarkable. A blood 
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sample was taken from the jugular vein, and the foal was given 
33 mg butylscopolamine (Buscopan compositum®, Boeringher 
Ingelheim), 2548 mg amoxicillin trihydrate (Clamoxyl LA®,  Pfizer), 
102 mg meloxicam (Rheumocam®, Chanelle), 680 mg α-tocopheryl 
acetate (Vitesel®, Norbrook) and 1 ml of tetanus vaccine (Equilis 
TE®, MSD, routine vaccination) intramuscularly. To reverse the 
anaesthetic, 47 mg naltrexone (Naltrexone 50 mg/ml, Kyron 
Prescriptions) was given intramuscularly. 
Biochemistry revealed a markedly increased plasma creatine 
kinase (CK) activity of 105,001 U/L (ISIS reference range: 98–1204 
U/L), an increased aspartate amino transferase (AST) activity of 
4194 U/L (97–597 U/L) and a mildly increased inorganic phosphorus 
concentration of 2.35 mmol/L (0.65–1.93 mmol/L).  All other values 
were within normal (ISIS) reference ranges. Haematology revealed 
a raised white blood cell count of 18.51*109/L (3.19–12.88*109/L), 
with a neutrophilia of 15.92*109/L (1.38–7.44*109/L, 86%). By the 
next morning the foal was lying in lateral recumbency covered 
in dried sweat, very unresponsive and could be approached to 
within two metres, highly unusual in wild equids. The foal was 
able to get up easily but stood at rest with its head hanging 
down continuously. In light of the blood results, the progressively 
worsening clinical signs and the potential to access sycamore seeds 
on the paddock, EAM associated with sycamore seed ingestion was 
suspected. To provide supportive therapy the foal was darted with 
1.6 mg etorphine, 12 mg midazolam and 150 IU hyaluronidase 
in its right quadriceps, but no effect of the drugs was apparent 
after 14 minutes. At this point, 170 mg of ketamine (Ketaset 10%, 
Pfizer) was added by dart in the same muscle, but no clinical effect 
could be seen, and compromised circulation in the muscle masses 
was suspected. A repeat injection of 1.6 mg etorphine and 150 
IU hyaluronidase was given intramuscularly 29 minutes after the 
initial induction dart. Twelve minutes later, the foal showed signs 
of high-stepping. At this point the foal could be separated from 
the herd into a sheltered area, where it showed signs of head-
pressing and went into sternal recumbency. Ketamine (85 mg) and 
midazolam (15 mg) were given intravenously, and the foal was 
successfully intubated.  
The heart rate was irregular and tachycardic, varying from 
100 bpm at the start of the anaesthetic to 92 bpm at the point 
of reversal. The respiratory rate varied between 8 and 24/
min and the rectal temperature was 39.7° C at the start of the 
anaesthetic and 39.0° C at the point of reversal. Over a period of 
45 minutes, the foal was given intravenous fluids at a flow rate 
of 20 ml/kg/h (2.5 litres Vetivex 11 Hartmanns, UK, with 375 ml 
Duphalyte®, Zoetis, UK). Additionally, 102 mg of meloxicam and 
1700 mg of marbofloxacin were given intramuscularly. After a 
prolonged recovery the foal remained depressed. The following 
morning the foal was tachypnoeic (more than 60 breaths/min) 
with a significant abdominal component, and covered in sweat. 
It was mainly recumbent. There was dark brown urine present in 
the enclosure. The foal was anaesthetised using 2 mg etorphine, 
12 mg midazolam and 150 IU hyaluronidase for induction, which 
took effect approximately 14 minutes post darting.  After fitting a 
blindfold, a jugular blood sample was obtained. Blood gas analysis 
showed hypoxaemia, respiratory acidosis and renal compensation 
(pH 7.210, pCO2 67.8 mmHg, pO2 95.5 mmHg, cHCO3 27.1 mmol/L, 
BE(ecf) -0.8 mmol/L, cSO2 95.2%, Na
+ 131 mmol/L, K+ 5.9 mmol/L, 
Ca2+ 1.12 mmol/L, Cl- 92 mmol/L, cTCO2 29.2 mmol/L, AGapk 
18 mmol/L, HCT 45%, cHgb 15.2 g/dL, Glu 4.4 mmol/L, Lac 7.95 
Figure 1. Clinical presentation of the Przewalski foal, with sudden-onset 
progressive weakness including sweating, an unresponsive demeanour 
and repeated stretching of the neck as if dysphagic.
Figure 2. (a) Striated muscle, longitudinal section. Multiple individual muscle fibres exhibit segmental areas of synchronous fibre degeneration (asterisks). 
Haematoxylin and eosin, scale bar 100 μm. (b) Oil red O stain showing sarcoplasmic lipid deposits in many fibres (typically slow twitch fibres).
a b
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mmol/L, Crea 268 μmol/L). Eight grams of quinalbarbitone 
(Somulose®, Dechra) was given intravenously for euthanasia.
The post-mortem examination was carried out the same day. The 
foal weighed 180 kg. There were minor abrasions around the hind 
feet from struggling to rise and/or recumbency (including during 
anaesthetic induction/recovery). The skeletal muscle groups had 
a very dry appearance. The heart muscles were mottled with a 
pale blue endocardium. The urinary bladder was distended with 
brown urine that emitted a strong odour and tested positive on 
urine dipsticks (Multistix® 10G, Siemens UK) for high (+++) levels 
of protein and haemo/myoglobin. The gastrointestinal tract 
contained normal ingesta throughout, with no evidence of toxic 
plant material. Samples of the skeletal muscles, myocardium and 
a variety of internal organs were fixed in 10% formalin, embedded 
in paraffin, cut and stained for histological examination. Additional 
samples of the skeletal musculature and myocardium were chilled 
overnight and submitted to a specialist laboratory prior to routine 
cryofreezing in isopentane, precooled in liquid nitrogen, with 
subsequent cryosectioning.
Histological abnormalities of the skeletal musculature were most 
readily identified in a longitudinally sectioned sample. There was 
moderate multifocal monophasic myopathy. Multiple individual 
muscle fibres exhibited segmental areas of approximately 
synchronous fibre necrosis with floccular degeneration and 
infiltration by small numbers of macrophages. Sarcolemmal 
sheaths remained intact, and myofibre nuclei were relatively 
normal and peripherally located. Affected fibres had mild satellite 
cell hyperplasia. Inflammation was not a feature, and there were 
unaffected fibres present between those with degenerative 
changes (Figure 2a). Oil red O-stain revealed a marked increase in 
sarcoplasmic lipid droplets in many fibres (Figure 2b). 
Urine organic acid analysis by gas chromatography/mass 
spectrometry revealed excretion of a number of abnormal 
metabolites including ethyl-malonate, butyryl glycine, iso-valeryl 
glycine, hexanoyl glycine and glutarate. The plasma acyl carnitine 
profile by  tandem mass spectrometry revealed normal free 
carnitine (37 μmol/L; expected normal human range 15–53 μmol/L) 
but marked increases in C4 (butyryl carnitine), C5 (pentanoyl-), C6 
(hexanoyl-), C5-hydroxy, C8 (octanoyl-), C10:1 (decenoyl-), C10 
(decanoyl-), C5-dicarboxylic (glutaryl-) C12:1 (dodecenoyl-) and 
C14:1 (tetradecenoyl-) with minor increases in C16 and C18:1 
carnitine esters (Table 1).
Discussion
The urinary organic acid and plasma acyl carnitine profiles were 
indicative of multiple acyl Co-A dehydrogenase deficiency. The 
histological changes within this muscle sample were also typical 
of hypoglycin A toxicity (Cassart et al. 2007; Valberg et al. 2013). 
Inhibition of multiple acyl Co-A dehydrogenase enzymes by 
hypoglycin A has been associated with EAM; it results in defective 
fatty acid oxidation in muscle mitochondria and the severe 
weakness displayed by affected animals. The most significant 
European tree whose seeds are known to contain hypoglycin A 
is the sycamore maple (Acer pseudoplatanus) (Unger et al. 2014). 
This particular tree is also the only one of the Acer family present 
in the mature woods that make up part of the Przewalski enclosure 
at ZSL Whipsnade Zoo, and at the time of the incident these trees 
bore large numbers of seeds. Therefore the EAM in this Przewalski 
foal was most likely associated with ingestion of sycamore seeds 
on pasture. Gillman et al. (2014) have found that there was 
variability in the hypoglycin A content of seeds from the same tree 
and between trees. The fact that only the foal was affected and 
none of the adults could therefore be due to its inquisitiveness 
to try new food stuffs at the point of weaning combined with the 
misfortune of consuming seeds with high hypoglycin A levels. 
Planned measures at the zoo to prevent future foals ingesting 
too many seeds include seasonally fencing off the woods, so that 
exposure can be reduced. This case demonstrates that EAM is not 
a disease limited to domestic equids but can equally affect their 
wild counterparts, and that foals at their time of weaning might 
be particularly at risk.
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